Approvals/TGA/CUVITRU normal immunoglobulin (human) infusion 20% for subcutaneous use in glass vial

Approved

STANDARD

CUVITRU normal immunoglobulin (human) infusion 20% for subcutaneous use in glass vial

Takeda Pharmaceuticals Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 79916fc8887f01c4
Product Name: CUVITRU normal immunoglobulin (human) infusion 20% for subcutaneous use in glass vial
Artg Id: 282579
Artg Name: CUVITRU normal immunoglobulin (human) infusion 20% for subcutaneous use in glass vial
Sponsor: Takeda Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/takeda-pharmaceuticals-australia-pty-ltd
Artg Date: 2017-10-05
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/b71d50deffe938abd1276266208eed2f.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/959c2f356dbf2668b1a6b6d3ae935a2d.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

79916fc8887f01c4

Type

Standard